1. Infect Genet Evol. 2020 Oct;84:104390. doi: 10.1016/j.meegid.2020.104390. Epub
 2020 Jun 4.

Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 
detection in the context of genetic variability of the virus in Colombia.

Álvarez-Díaz DA(1), Franco-Muñoz C(2), Laiton-Donato K(3), Usme-Ciro JA(4), 
Franco-Sierra ND(5), Flórez-Sánchez AC(6), Gómez-Rangel S(7), Rodríguez-Calderon 
LD(8), Barbosa-Ramirez J(9), Ospitia-Baez E(10), Walteros DM(11), 
Ospina-Martinez ML(12), Mercado-Reyes M(13).

Author information:
(1)Unidad de Secuenciación y Genómica, Dirección de Investigación en Salud 
Pública, Instituto Nacional de Salud, Bogotá 111321, Colombia; Grupo de Salud 
Materna y Perinatal, Dirección de Investigación en Salud Pública, Instituto 
Nacional de Salud, Bogotá 111321, Colombia. Electronic address: 
daalvarezd@unal.edu.co.
(2)Unidad de Secuenciación y Genómica, Dirección de Investigación en Salud 
Pública, Instituto Nacional de Salud, Bogotá 111321, Colombia; Grupo de 
Parasitología, Dirección de Investigación en Salud Pública, Instituto Nacional 
de Salud, Bogotá 111321, Colombia. Electronic address: cefrancom@unal.edu.co.
(3)Unidad de Secuenciación y Genómica, Dirección de Investigación en Salud 
Pública, Instituto Nacional de Salud, Bogotá 111321, Colombia. Electronic 
address: kdlaitond@unal.edu.co.
(4)Unidad de Secuenciación y Genómica, Dirección de Investigación en Salud 
Pública, Instituto Nacional de Salud, Bogotá 111321, Colombia; Centro de 
Investigación en Salud para el Trópico-CIST, Universidad Cooperativa de 
Colombia, Santa Marta 470003, Colombia. Electronic address: 
jose.usmec@ucc.edu.co.
(5)Programa Ciencias de la Biodiversidad, Instituto de Investigación de Recursos 
Biológicos Alexander von Humboldt, Bogotá 111311, Colombia. Electronic address: 
nfranco@humboldt.org.co.
(6)Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá 
111321, Colombia. Electronic address: aflorez@ins.gov.co.
(7)Grupo de Virología, Dirección de Redes en Salud Pública, Instituto Nacional 
de Salud, Bogotá 111321, Colombia. Electronic address: sgomezr@ins.gov.co.
(8)Grupo de Virología, Dirección de Redes en Salud Pública, Instituto Nacional 
de Salud, Bogotá 111321, Colombia. Electronic address: lrodriguez@ins.gov.co.
(9)Grupo de Virología, Dirección de Redes en Salud Pública, Instituto Nacional 
de Salud, Bogotá 111321, Colombia. Electronic address: jbarbosa@ins.gov.co.
(10)Grupo de Virología, Dirección de Redes en Salud Pública, Instituto Nacional 
de Salud, Bogotá 111321, Colombia. Electronic address: eospitia@ins.gov.co.
(11)Dirección de Vigilancia en Salud Pública, Instituto Nacional de Salud, 
Bogotá 111321, Colombia. Electronic address: dwalteros@ins.gov.co.
(12)Dirección General, Instituto Nacional de Salud, Bogotá 111321, Colombia. 
Electronic address: mospina@ins.gov.co.
(13)Unidad de Secuenciación y Genómica, Dirección de Investigación en Salud 
Pública, Instituto Nacional de Salud, Bogotá 111321, Colombia; Grupo de Salud 
Materna y Perinatal, Dirección de Investigación en Salud Pública, Instituto 
Nacional de Salud, Bogotá 111321, Colombia; Dirección de Investigación en Salud 
Pública, Instituto Nacional de Salud, Bogotá 111321, Colombia. Electronic 
address: mmercado@ins.gov.co.

The COVID-19 pandemic caused by SARS-CoV-2 is a public health problem 
unprecedented in the recent history of humanity. Different in-house real-time 
RT-PCR (rRT-PCR) methods for SARS-CoV-2 diagnosis and the appearance of genomes 
with mutations in primer regions have been reported. Hence, whole-genome data 
from locally-circulating SARS-CoV-2 strains contribute to the knowledge of its 
global variability and the development and fine tuning of diagnostic protocols. 
To describe the genetic variability of Colombian SARS-CoV-2 genomes in 
hybridization regions of oligonucleotides of the main in-house methods for 
SARS-CoV-2 detection, RNA samples with confirmed SARS-CoV-2 molecular diagnosis 
were processed through next-generation sequencing. Primers/probes sequences from 
13 target regions for SARS-CoV-2 detection suggested by 7 institutions and 
consolidated by WHO during the early stage of the pandemic were aligned with 
Muscle tool to assess the genetic variability potentially affecting their 
performance. Finally, the corresponding codon positions at the 3' end of each 
primer, the open reading frame inspection was identified for each gene/protein 
product. Complete SARS-CoV-2 genomes were obtained from 30 COVID-19 cases, 
representative of the current epidemiology in the country. Mismatches between at 
least one Colombian sequence and five oligonucleotides targeting the RdRP and N 
genes were observed. The 3' end of 4 primers aligned to the third codon 
position, showed high risk of nucleotide substitution and potential mismatches 
at this critical position. Genetic variability was detected in Colombian 
SARS-CoV-2 sequences in some of the primer/probe regions for in-house rRT-PCR 
diagnostic tests available at WHO COVID-19 technical guidelines; its impact on 
the performance and rates of false-negative results should be experimentally 
evaluated. The genomic surveillance of SARS-CoV-2 is highly recommended for the 
early identification of mutations in critical regions and to issue 
recommendations on specific diagnostic tests to ensure the coverage of 
locally-circulating genetic variants.

Copyright © 2020 Elsevier B.V. All rights reserved.

DOI: 10.1016/j.meegid.2020.104390
PMCID: PMC7272177
PMID: 32505692 [Indexed for MEDLINE]

Conflict of interest statement: Declaration of Competing Interest The authors 
declare that there is no conflict of interest in the manuscript.